Hexarelin hmoovyog ib qho ntshiab heev, khov -cov hmoov hluavtaws peptide qhuav, nthuav tawm raws li cov hmoov dawb, zoo hauv nws daim ntawv acetate. Nws nthuav tawm cov tshuaj lom neeg ruaj khov thiab solubility zoo heev, thiab tuaj yeem rov tsim kho sai nrog cov dej tsis huv lossis cov kab mob bacteriostatic, haum rau ntau yam kev siv hauv kev tshawb fawb.
Nws khi ruaj khov rau kev loj hlob hormone secretagogue receptors, txhawb nqa pulsatile tso tawm ntawm endogenous txoj kev loj hlob hormone, thiab exerts ntau yam cuam tshuam nrog rau cardioprotection thiab metabolic regulation.Manufactured los ntawm khov- tshuab ziab khaub ncaws, cov hmoov tsis tas yuav tsum tau tub yees thaum lub sij hawm thauj, thiab luv luv -lub sij hawm kub fluctuations. Ntev- lub sij hawm cia nyob rau hauv qhov qis - qhov kub thiab txias ib puag ncig zoo tiv thaiv deliquescence thiab tiv thaiv nws txoj haujlwm lom neeg.
Peb Cov Khoom Muag Khoom
Hexarelin COA
I. Core Mechanisms ntawm Cardioprotection los ntawm cov khoom
Direct Cardiomyocyte Protection Mediated los ntawm Target Receptors
Hexarelin hmoovKev xaiv zoo heev khi rau kev loj hlob hormone secretagogue receptors (GHS-R1a) ntawm cardiomyocyte daim nyias nyias, bypassing cov tshuaj hormones loj hlob axis thiab ncaj qha activating endogenous myocardial tiv thaiv signaling.
Qhov no receptor yog qhia rau cardiomyocytes, vascular endothelial hlwb, thiab cov leeg nqaij du. Thaum ua kom muaj zog, nws ceev ceev tswj cov calcium homeostasis, inhibits oxidative kev nyuaj siab, thiab thaiv txoj kev apoptotic. Piv nrog rau lwm cov GHRPs, nws qhia tau hais tias muaj kev sib raug zoo dua rau GHS-R1a thiab qeeb desensitization, ua kom cardioprotection ntawm cov koob tshuaj qis dua thiab ntev dua. Qhov no tseem yog qhov tseem ceeb rau nws txoj kev ua haujlwm ruaj khov tom qab rov tsim kho dua tshiab.
Kev kho ntawm Mitochondrial Homeostasis thiab Optimization ntawm Zog Metabolism
Mitochondrial dysfunction yog ib txoj hauv kev hauv ntau hom kev mob plawv. Cov khoom lag luam txhawb nqa cov yam tseem ceeb suav nrog PGC-1 thiab Nrf2, txhim kho mitochondrial biogenesis thiab qhov sib npaug ntawm fission thiab fusion, txhim kho ATP ntau lawm efficiency, thiab txo cov pa oxygen reactive hom (ROS) tsub zuj zuj.
Nws stabilizes mitochondrial membrane muaj peev xwm, txo cytochrome c tso, thiab thaiv cov endogenous apoptotic cascade. Rau mitochondrial vau tshwm sim los ntawm ischemia, hypoxia, siab qabzib, lossis tshuaj lom tshuaj lom neeg, cov khoom lag luam kho cov kab mob ua pa sai sai, txo cov teebmeem ntawm lub zog myocardial, thiab muab kev txhawb nqa metabolic rau myocardium puas.
Dual Inhibition ntawm Oxidative Stress thiab Inflammatory Teb
Oxidative stress thiab inflammatory amplification ua rau kev loj hlob ntawm myocardial raug mob. Cov khoom no nce cov kev ua ub no ntawm antioxidant enzymes xws li SOD thiab GSH-Px, txo cov qib ntawm oxidative cim xws li MDA thiab 8-OHdG, thiab alleviates lipid peroxidation thiab oxidative DNA puas.
Lub caij no, nws inhibits NF-κB thiab NLRP3 inflammasome txoj hauv kev, txo qis kev tso tawm ntawm pro-inflammatory cytokines xws li TNF- , IL-1 , thiab IL-6, thiab txo myocardial inflammatory infiltration thiab pib ntawm fibrosis. Qhov no dual antioxidant + anti-inflammatory mechanism muab kev tiv thaiv dav dav hauv ob qho tib si mob plawv thiab mob plawv.
Blockade ntawm Cardiomyocyte Apoptosis thiab Programmed Cell Tuag
Hexarelin hmoovtxo qis cardiomyocyte apoptosis los ntawm kev tswj hwm Bcl-2 / Bax piv thiab inhibiting qhov cleavage thiab activation ntawm Caspase-3/9. Hauv cov qauv ntawm ischemia-reperfusion, plawv tsis ua hauj lwm, thiab tshuaj kho mob-induced cardiotoxicity, nws txo TUNEL-zoo cell tus nqi thiab tswj cardiomyocyte suav thiab contractile kev ncaj ncees.
Tsis tas li ntawd, cov hmoov atenuates pyroptosis thiab ferroptosis hauv cardiomyocytes, thaiv cov txheej txheem ntawm tes tuag los ntawm ntau lub hom phiaj thiab tsim lub sijhawm rau kho myocardial.
II. Kev tiv thaiv zoo ntawm cov khoom hauv cov qauv mob plawv
Anti-Myocardial Ischemia/Reperfusion (I/R) Kev raug mob
Myocardial ischemia-reperfusion yog ib qho teeb meem loj uas feem ntau pom tom qab mob myocardial infarction, mob plawv, lossis poob siab. Nws txo qhov loj me me, txhim kho ventricular phab ntsa suab, thiab txo qhov tshwm sim ntawm arrhythmias thaum siv rau pretreatment, tom qab kev kho mob, lossis kev cuam tshuam tas mus li.
Nws cov nqi tseem ceeb nyob rau hauv attenuating oxidative tawg thiab calcium overload thaum lub sij hawm reperfusion, tiv thaiv endothelial barrier, thiab txhim kho microcirculatory perfusion. Cov kev tshawb fawb pom tau tias hauv I / R cov qauv, nws txo qis myocardial infarct loj los ntawm ntau dua 40%, txhim kho sab laug ventricular ejection feem, txo troponin thiab LDH to, thiab txhim kho plawv ciaj sia.
Txhim kho lub plawv Failure thiab Pathological Myocardial Remodeling
Lub plawv tsis ua hauj lwm yog tus yam ntxwv los ntawm myocardial hypertrophy, interstitial fibrosis, ventricular dilation, thiab impaired systolic thiab diastolic muaj nuj nqi.Hexarelin hmoovinhibits pathological hypertrophy ntawm cardiomyocytes, downregulates hypertrophic markers xws li ANP, BNP, thiab -MHC, txo hom I/III collagen deposition thiab TGF-1 txoj kev ua kom, thiab thim rov qab interstitial fibrosis thiab ventricular remodeling.
Nws txhim kho myocardial contractility, txo qis ventricular filling siab, txhim kho ejection feem thiab diastolic muaj nuj nqi, thiab txo cov neurohormonal ua kom ntau dhau thiab plawv dhau los ntawm kev nce Ang II thiab aldosterone. Cov khoom no qhia tau hais tias muaj txiaj ntsig zoo nyob rau hauv lub plawv tsis ua haujlwm tom qab mob plawv, lub plawv tsis ua haujlwm siab, thiab cov qauv metabolic plawv tsis ua haujlwm.
Attenuation of Chemotherapy-Induced Cardiotoxicity
Cov tshuaj kws khomob uas sawv cev los ntawm doxorubicin feem ntau ua rau kev siv tshuaj ntau dua, tsis tuaj yeem raug mob myocardial, txwv kev ua haujlwm ntawm cov qog noj ntshav. Cov khoom no txo qis doxorubicin-induced myocardial fiber ntau o, vacuolar degeneration, thiab inflammatory infiltration los ntawm ntau txoj kev xws li antioxidation, anti-o, anti-apoptosis, thiab mitochondrial tiv thaiv, txo myocardial enzyme tso tawm, thiab khaws cia cov qauv plawv thiab kev ua haujlwm.
Nws txoj kev loj hlob hormone-kev ywj pheej ncaj qha cov cuab yeej cardioprotective ua rau nws yog tus neeg sawv cev tiv thaiv zoo tshaj plaws hauv kev tshawb fawb cardio-oncology, txo qis kev pheej hmoo ntawm plawv yam tsis cuam tshuam nrog kev kho mob qog.
Kev Tiv Thaiv Tiv Thaiv Mob Ntshav Qab Zib Cardiomyopathy thiab Metabolism-Related Cardiac Injury
Cov piam thaj siab, insulin tsis kam, thiab lipotoxicity yog cov txheej txheem tseem ceeb ntawm kev mob ntshav qab zib mob plawv. Cov khoom no txhim kho myocardial insulin rhiab heev, txhawb nqa cov piam thaj thiab siv, thiab txo lipotoxicity-induced myocardial apoptosis thiab fibrosis.
Nws relieves oxidative kev nyuaj siab thiab o nyob rau hauv cov ntshav qab zib myocardium, tiv thaiv microvascular endothelial muaj nuj nqi, thiab ncua kev loj hlob ntawm sab laug ventricular hypertrophy thiab diastolic dysfunction, muab ib tug txhim khu kev qha cuab yeej rau kev tshawb fawb thiab kev cuam tshuam cov tswv yim rau metabolic lub plawv.
III. Cov txiaj ntsig tshwj xeeb ntawm Cov Khoom Siv raws li Cardioprotective Tool Peptide
Kev sim kev ruaj ntseg los ntawm High-Purity Powder Form
Hexarelin hmoovyog tsim los ntawm freeze-drying, tshwm raws li ib tug dawb, zoo hmoov uas tsis pom impurities. Tom qab rov kho dua, nws yog qhov tseeb thiab pob tshab yam tsis muaj nag lossis daus, ua kom muaj kev tswj hwm tsis tu ncua.
Nrog HPLC purity Ntau dua los yog sib npaug rau 99%, nws tshem tawm kev cuam tshuam los ntawm impurities, kom ntseeg tau tias qhov kev sim tau raug ntaus nqi rau peptide nws tus kheej es tsis yog excipients lossis kab mob. Nws qhia tau hais tias siab batch-to-batch stability, haum rau lub sij hawm ntev, loj-piv txwv, multi-center cardiovascular mechanistic kev tshawb fawb.
Pharmacological Properties of Low Desensitization thiab Long-Lasting Stability
Tsis zoo li lwm yam GHRPs uas tau dhau los ua qhov tsis txaus ntseeg sai, nws khaws cov receptor ua kom muaj txiaj ntsig zoo thiab tsis tu ncua ua rau cov teeb liab cardioprotective tom qab rov ua haujlwm dua.
Qhov no low-desensitization profile ua rau nws muaj txiaj ntsig zoo hauv kev tshawb fawb uas xav tau kev cuam tshuam mus sij hawm ntev, xws li mob plawv tsis ua hauj lwm thiab mob ntshav qab zib cardiomyopathy, zam qhov txo qis ntawm kev tiv thaiv los ntawm receptor downregulation.
Direct Cardioprotection Independent ntawm GH Axis
Cov khoom lag luam ua ncaj qha rau ntawm myocardial GHS-R1a, tsis muaj kev cia siab rau kev loj hlob hormone tso tawm. Nws muab kev tiv thaiv tsis ncaj los ntawm GH / IGF-1 axis thiab nws tus kheej qhib txoj hauv kev tiv thaiv myocardial endogenous.
Cov yam ntxwv no tso cai rau nws ua haujlwm zoo hauv cov qauv kab mob plawv nrog kev loj hlob tsis zoo ntawm cov tshuaj hormone axes lossis qhov twg GH cuam tshuam tsis zoo, nthuav dav nws daim ntawv thov scenarios.
Kev khaws cia yooj yim thiab kev thauj mus los nrog kev khaws cia tag nrho ntawm Bioactivity
Cov hmoov khov-qhuav tso cai rau kev thauj mus los luv luv ntawm chav tsev kub thiab lub sijhawm ntev cia ntawm qhov kub thiab txias yam tsis muaj qhov txias txias, txo cov nqi sim thiab poob.
Kev kho dua tshiab yog qhov yooj yim thiab nrawm, txhawb nqa cov hlab ntsha, intraperitoneal, subcutaneous, thiab lwm txoj hauv kev ntawm kev tswj hwm kom ua tau raws li qhov xav tau ntawm cov qauv tsiaj sib txawv thiab cov kev sim ntawm tes, thaum kawg khaws cia bioactivity.
IV. Daim ntawv thov kev cia siab nyob rau hauv Basic thiab Translational Cardiovascular Research
Nrog ntau lub hom phiaj, ntau txoj hauv kev, ua haujlwm tau zoo thiab ruaj khov cardioprotective muaj peev xwm, cov khoom tau dhau los ua cov cuab yeej nrov peptide hauv kev tshawb fawb plawv.
Hauv kev tshawb fawb hauv paus, nws tau siv dav hauv cov qauv ntawm myocardial ischemia-reperfusion, lub plawv tsis ua haujlwm, mob ntshav qab zib cardiomyopathy, thiab tshuaj kho mob-induced cardiotoxicity los txiav cov txheej txheem suav nrog GHS-R1a signaling, mitochondrial homeostasis, o, apoptosis, thiab myocardial remodeling. perioperative myocardial tiv thaiv cov tswv yim, thiab kev kho mob ua ke rau lub plawv tsis ua hauj lwm.
Nrog rau kev nce qib ntawm precision cardioprotection thiab kev tshawb fawb tiv thaiv kab mob, tus nqi ntawmHexarelin hmoovyuav tseem ceeb ntxiv. Nws cov purity siab, ruaj khov, thiab yooj yim ntawm kev siv ua rau nws nyiam cov khoom siv rau kev soj ntsuam kuaj, muab cov cuab yeej txhim khu kev qha rau kev kho mob myocardial infarction, kev tiv thaiv kev phais plawv, thim rov qab ntawm lub plawv tsis ua hauj lwm, thiab qog cardioprotection, txhawb kev nce qib los ntawm kev tshawb nrhiav kev kho mob rau kev kho mob txhais lus.
GHRP Tsev Neeg thiab Cov Qauv Tsim Kho Tshiab
Kev tshawb pom ntawm Hexarelin pib los ntawm kev hloov kho ntawm GHRP-6. Xyoo 1970s, cov kws tshawb fawb pom tias endorphin derivatives tuaj yeem txhawb kev loj hlob hormone (GH) tso tawm, tso lub hauv paus rau GHRP tsev neeg.
Los ntawm lig 1980s mus rau thaum ntxov 1990s, cov kws tshawb fawb los ntawm Mediolanum Farmaceutici (Ltalis) thiab Tulane University (USA) tau koom tes los ua cov kev hloov pauv molecular raws li GHRP-6. Hloov D-tryptophan nrog D-2-methyltryptophan ua tau zoo txhim kho enzymatic stability thiab receptor affinity, thiab Hexarelin (kev loj hlob code: EP-23905 / MF-6003; generic lub npe: Examorelin) tau raug tsim.
Nws cov haujlwm lom neeg tau nthuav tawm thawj zaug ntawm International Growth Hormone Conference nyob rau hauv 1992, tsim nws cov xwm txheej raws li muaj zog GH-tso peptide.
Txhim kho kev ruaj ntseg thiab kev ua haujlwm
Piv nrog rau GHRPs thaum ntxov, qhov tseem ceeb ntawm nws yog nyob rau hauv molecular stability thiab kev ua haujlwm ntev. Kev hloov kho Methylation txuas ntxiv nws cov ntshav ib nrab ntawm lub neej mus rau 50-75 feeb, zoo dua rau GHRP-6. Nws qhia tau hais tias tsis tshua muaj tachyphylaxis thiab tswj kev ua haujlwm siab nrog kev rov ua haujlwm dua.
Cov hmoov yog npaj los ntawm khov-qhuav nrog HPLC purity Ntau dua los yog sib npaug li 99%, tsis muaj kev cuam tshuam tsis huv thiab nrog kev ua kom muaj roj ntsha muaj peev xwm khaws cia, daws cov teeb meem ntawm peptide degradation yooj yim thiab kev sim tsis zoo.
Ntau qhov kev tshawb fawb tsiaj thiab preclinical los ntawm 1993 txog 1995 tau lees paub tias nws GH-tso potency, koob tshuaj, thiab kev nyab xeeb mus txog qib ntawm cov peptides zoo sib xws.
Los ntawm Endocrinology mus rau Cardioprotection
Tom qab xyoo 1999, cov kev tshawb fawb tau qhia tias Hexarelin activates myocardial GHS-R1a thiab tiv thaiv lub plawv ncaj qha ntawm GH axis, ua txhaum los ntawm nws lub luag haujlwm ib txwm ua raws li endocrine peptide.
Los ntawm 2000 mus rau 2010, ntau cov kev tshawb fawb tau lees paub nws cov kev tiv thaiv nyob rau hauv myocardial ischemia-reperfusion raug mob, plawv tsis ua hauj lwm, thiab chemotherapy-induced cardiotoxicity, tsim nws raws li ib tug nrov cuab tam peptide nyob rau hauv kev tshawb fawb plawv. Nws ruaj khov, khaws tau yooj yim hmoov daim ntawv, yuav tsum tsis muaj kev thauj mus los txias, txhawb ntau yam kev xav tau kev tshawb fawb thiab ua kom ceev cov kev tshawb fawb thiab kev txhais lus.
Standardized Tool Peptide hauv Kev Tshawb Fawb Txog Kev Tshawb Fawb
Nyob rau hauv lub xyoo pua 21st, cov khoom tau hloov los ntawm ib tug neeg sib tw tshuaj mus rau ib tug standardized tshawb fawb reagent. Nws cov purity siab, tsis tshua muaj impurity profile, thiab batch-stable hmoov daim ntawv tau ua nws ib tug universal khoom nyob rau hauv txoj kev loj hlob hormone tswj, metabolism, thiab cardioprotection.
Nws txoj kev tshawb pom keeb kwm qhia txog peptide R & D txoj hauv kev: kev hloov pauv molecular hauv paus → kev ua haujlwm zoo → nthuav tawm cov lus qhia tshiab, thiab lees paub tus nqi tseem ceeb ntawm cov hmoov tsim rau kev tshawb fawb peptide.
FAQ
Hexarelin siv rau dab tsi?
+
-
Hexarelin yog ib qho muaj zog hluavtaws loj hlob hormone- tso peptide (GHRP) siv los txhawb lub caj pas pituitary los tsim cov tshuaj hormones loj hlob (GH). Nws yog siv los txhim kho lub cev muaj pes tsawg leeg (ua kom cov nqaij ntshiv, txo cov rog), txhim kho kev rov qab los ntawm kev raug mob lossis kev tawm dag zog, txhawb kev mob plawv, thiab ua kom cov pob txha pob txha pob txha.
Puas yog Hexarelin zoo ib yam li MK677?
+
-
Tsis zoo li peptide Hexarelin, MK677 yog ib yam tsis yog -peptide cov khoom uas muaj txiaj ntsig zoo thiab ntev ntev - lub qhov ncauj ua haujlwm ghrelin receptor agonist thiab kev loj hlob hormone secretagogue uas ua raws li GH stimulating teebmeem ntawm endogenous hormone ghrelin.
Puas yog Hexarelin zoo rau cov leeg nqaij?
+
-
Cov peptide no tau txais kev saib xyuas ntau hauv endocrinology thiab cov tshuaj kis las vim nws qhov kev ua tau zoo hauv kev txhawb nqa cov leeg nqaij ntshiv kev loj hlob, txhim kho cov metabolism hauv rog, txhim kho cov hlab plawv, thiab muab cov txiaj ntsig tiv thaiv - mob.
Cim npe nrov: Tuam Tshoj hexarelin hmoov manufacturers, lwm tus neeg
